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Abstract 
Background: In response to transforming healthcare and pursuit of the Triple Aim, many health systems have added team members to 
expand the capabilities and effectiveness of the team to facilitate these aims. The objective of this study was to explore knowledge and 
perceptions of pharmacist-physician collaboration among family medicine residents (FMR), family medicine faculty (FMF), and 
pharmacist faculty and residents in a practice where clinical pharmacy services were relatively new. Understanding the nuances of 
pharmacist-physician interactions will provide insight into how to improve FMR education to prepare learners for patient-centered, team-
based practice. 
Methods: An exploratory descriptive qualitative study design was used to articulate perceptions of professional roles and team-based 
care in an interprofessional family medicine community-based clinical practice. Five, 60-minute focus groups were conducted in a clinical 
training setting that focuses on preparing family medicine physicians for collaborative rural primary care practice. 
Results: Twenty-one FMRs, eight FMF, and six clinical pharmacists participated. Three themes emerged from the focus groups and were 
consistent across the groups: 1) roles of pharmacists recognized by physicians in different settings, 2) benefits to collaboration, and 3) 
keys to successful pharmacist-physician collaboration which include a) developing the relationship, b) optimizing communication, c) 
creating beneficial clinical workflow, d) clarifying roles and responsibilities, and e) increasing opportunities for meaningful interactions. 
Conclusion: This study demonstrated that by co-locating physicians and pharmacists in the same environment, and providing a basic 
structure for collaboration, a collaborative working relationship can be initiated. Practices looking to have more effective collaborative 
working relationships should strive to increase the frequency of interactions of the professions, help the physicians understand the 
abilities of pharmacists, and help the pharmacists articulate to the physicians the value of what they provide to patients. The five keys 
identified in this study are building blocks to advance a successful collaborative working relationship that positively benefits patient care 
and achieves the Quadruple Aim. 
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BACKGROUND 
The healthcare system in the United States has begun to focus on 
achieving the Triple Aim: improved health of populations, 
improved individual experience of care including outcomes and 
satisfaction, and reduced population per capita cost of care.1,2 
Collaboration across professions in patient care plays a significant 
role in the success of the Triple Aim, and healthcare professionals 
must be properly trained to provide this collaborative care.1,2 
While the Triple Aim addresses the outcomes of health system 
services, a revised version, the Quadruple Aim, also addresses the 
health of individuals who provide patient care.3 Studies show that 
burnout is high among physicians, with family medicine 
physicians experiencing one of the highest burnout rates in 
medical practice.4,5 Bodenheimer and Sinsky suggested using a 
team approach to the provision of patient care in order to better 
balance the physician’s workload.3 Pharmacists, a relative 
newcomer to the outpatient clinical team, can positively impact 
patient care by performing some of the tasks historically done by 
physicians, which can alleviate physician burnout.6 When  
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pharmacists are a member of the primary care team, they 
provide benefits, such as answering drug information questions, 
communicating with the team about medication issues, 
increasing prescribing safety, and educating patients and 
providers.7-11 The literature also provides strong support for 
pharmacist-physician collaboration to improve health outcomes, 
as shown through significantly improved patient A1c, blood 
pressure, and asthma control after pharmacist interventions.12-18 
When pharmacists are a part of the healthcare team, physicians 
see value in their services.7,8,11 
 
While it is well understood that a pharmacist-physician 
collaboration model can improve health outcomes, the methods 
for fostering these collaborations is less clear. Brock and 
Doucette tested a model of collaborative working relationships 
between physicians and pharmacists, which shows that this 
collaboration goes through five stages.19 These stages start with 
professional awareness (stage 0), move through professional 
recognition (stage 1), exploration and trial (stage 2), and 
professional relationship expansion (stage 3), and end with a 
commitment to a collaborative working relationship (stage 4).  
However, the model was tested with practitioners who had been 
in practice an average of at least 14 years, and with pharmacists 
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practicing in community pharmacies rather than co-located with 
physicians. 
 
Interprofessional learning begins early in a health profession 
student’s education and accelerates into graduate training as 
residents and finally as healthcare professionals.20 In Family 
Medicine, the Accreditation Council for Graduate Medical 
Education (ACGME) emphasizes the importance of team-based 
care. Residents are assessed on their understanding of roles and 
responsibilities of healthcare team members and their ability to 
engage in appropriate team-based care.21 Examination of this 
graduate level of training may provide a better understanding of 
how to improve pharmacist/physician collaboration. 
Understanding underlying knowledge and perceptions of 
pharmacist/physician collaboration may guide interventions to 
intentionally enhance collaboration.  In the health sciences 
education literature, this is an area with limited published data.9 
Additionally, there is little research about knowledge and 
perceptions of collaboration among pharmacists involved in 
Family Medicine residency programs.  
  
The objective of this study was to explore knowledge and 
perceptions of pharmacist-physician collaboration among family 
medicine residents (FMR), family medicine faculty (FMF), and 
pharmacists (P), including pharmacist faculty and pharmacy 
residents.  This information will provide insight for improvement 
of FMR education to better prepare learners for patient-
centered, team-based practice.  
 
METHODS 
Research Design 
An exploratory, descriptive, qualitative study design was used to 
articulate perceptions of professional roles and team-based care 
in an interprofessional family medicine community-based clinical 
practice. 
 
Setting 
The study took place from January 8 to May 11, 2015 at the 
Duluth Family Medicine Residency Program (DFMRP), an affiliate 
of the University of Minnesota School of Medicine Department of 
Family Medicine and Community Health located in Duluth, 
Minnesota. DFMRP’s goal is to prepare family medicine 
physicians for collaborative rural primary care practice.22 This 
primary care practice is comprised of family medicine faculty 
(including behavioral health and social work faculty), family 
medicine residents (first year, G1; second year, G2; third year, 
G3), ambulatory clinical pharmacists, and rotating pharmacy 
residents.  The clinical pharmacists had been providing 
comprehensive medication management services in the clinic for 
2.5 years at the time the study took place.23 The care team also 
includes nurses, medical assistants, and other clinic staff. The 
family medicine residents have progressively more time in the 
clinic, ranging from two to four half-days per week, and see an 
average of six patients per half-day. Team huddles occur prior to 
each shift, and all health professionals are co-located in a team 
area with each profession available for care conferences.   
 
Participants 
Given the study objective to explore knowledge and perceptions 
of pharmacist-physician collaboration, the investigators used 
purposive sampling and selected the following providers 
affiliated with DFMRP: FMR (G1, n=8; G2, n=10; G3, n=9), FMF 
(physicians, n=6; behavioral health practitioners, n=2), 
ambulatory clinical pharmacists from the clinic (n=2), and 
pharmacy residents from the clinic (n=2) and hospital (n=2) 
where the FMRs interacted. FMR trainees and their faculty, as 
well as pharmacists, were included to get diverse perspectives of 
pharmacist-physician collaboration in the clinic. The ambulatory 
clinical pharmacists and pharmacy residents were combined into 
one group because of their small number and because they all 
provide comprehensive medication management services. In 
addition, the authors reasoned that medical residents with more 
exposure to clinical pharmacy services (i.e., residents further 
along in their training) may have differing opinions about 
pharmacist-physician collaboration than earlier learners. 
Therefore, the FMR focus groups were divided into G1, G2, and 
G3 resident cohorts.  
 
Interview Guide 
An interview guide comprised of seven questions and 
corresponding probes was developed by one of the authors (KH) 
to facilitate discussions about knowledge and perceptions of 
professional roles and team collaboration. Prior to using the 
interview guide, the questions and probes were reviewed by 
members of an interprofessional education advisory board that 
was comprised of the residency program director and the two 
ambulatory clinical pharmacists. This board was chosen to 
provide critical feedback because of their clinical expertise, 
interest in understanding FMR perceptions of collaboration with 
pharmacists, and support of enhanced collaboration between 
physicians and pharmacists. Several of the interview questions 
were tailored specifically for pharmacists.  For example, the 
question “What is the pharmacist’s role/responsibility in team-
based care?” used with the FMRs and FMFs was reworded to 
“What are your roles/responsibilities in team-based care?” when 
speaking to the pharmacists.  The interview guide is provided in 
Appendix A.  
 
Data Collection Procedure 
Five, 60-minute focus groups were conducted for this study: (1) 
FMR - G1, (2) FMR - G2, (3) FMR - G3, (4) FMF, and (5) ambulatory 
clinical pharmacists and pharmacy residents. The FMR and FMF 
focus groups were conducted in the Family Medicine Clinic during 
a regularly scheduled one-hour meeting, whereas the pharmacist 
group was conducted at another primary care clinic site within 
the health system. Participants were invited to participate either 
by the residency program director (physician groups) or the 
ambulatory clinical pharmacist (pharmacist group) in person or 
by email. Focus groups were facilitated by one author (KH), who 
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was not part of the clinical site, but was known by some of the 
participants through her work with their interprofessional 
education advisory group. Focus groups were audio recorded and 
transcribed verbatim. A pharmacy student took notes during 
each interview to supplement the transcript data. This research 
was approved by the University of Minnesota Institutional Review 
Board and was exempt from full review. 
 
Data Analysis 
Content analysis of transcripts was conducted by the four 
investigators using a classic analysis strategy.24 Coding of the 
transcripts was completed manually in three steps. In the first 
step, two authors (KH, CM) independently coded the transcripts 
and came to consensus on codes and categories through 
discussion. Once consensus was achieved, a third author (DU) 
independently coded the transcripts. The three coders then 
arrived at consensus on codes and categories through discussion. 
To strengthen the rigor of the data analysis, the investigators 
invited a physician (BS) to code all of the data independently. 
Following this independent analysis, all four coders came to 
consensus on the main themes and subthemes that emerged 
from the data. The coders started with open coding of the text 
and then proceeded to develop categories using axial coding.25 
For example, the open codes of “pharmacist role – medication 
reviews (clinic),” “pharmacist role – medication adherence 
(clinic),” and “pharmacist role – prevention (clinic),” were later 
merged into an overarching category called "pharmacist role – 
clinic." A multistage data analysis procedure was implemented to 
ensure that no new themes emerged from the data and 
theoretical saturation was achieved for each of the identified 
themes and subthemes.26 The study participants did not review 
any of the transcripts; however, a summary of findings and 
recommendations was presented to the residency program 
director and the interprofessional education advisory group 
members for their review and feedback. This step was added to 
assess the credibility and overall trustworthiness of the study 
findings.27  
 
RESULTS 
Twenty-one out of 27 family medicine residents (7 G1, 8 G2, 6 
G3), 8 family medicine faculty, and 6 pharmacists participated in 
the focus groups. The analysis of the focus groups yielded three 
primary themes and corresponding subthemes (Table 1). Details 
of the themes and supporting quotes are provided below.  
Attribution for each of the quotes is given as FMF (family 
medicine faculty), FMR (family medicine resident) and P 
(pharmacist).  The FMRs are listed by year of residency G1-G3.  
The individual participants are designated by M (male) or F 
(female) and a number. 
 
Theme 1: Roles of pharmacists in different settings were 
recognized by physicians   
The physician’s view of the pharmacist’s role varied based on the 
setting – clinic, hospital, or community. Additionally, the way that 
the physician interacted and communicated with the pharmacist 
in each of those settings varied. 
 
Clinic  
FMRs and FMF described clinical pharmacy services in the 
outpatient clinic as a comprehensive review of medications, 
including preventive items (e.g., immunizations due). FMRs 
expressed that pharmacists in the outpatient clinic have a 
substantial role in patient medication adherence. While the 
pharmacists conduct comprehensive medication management, it 
is not clear if the FMRs and FMF understand that this is more than 
medication review. Interaction with the pharmacist in the clinic 
occurred primarily out of convenience. If a FMR was in the clinic 
and no clinical pharmacist was present, the FMR telephoned a 
pharmacist at the hospital on the floor or in the central 
pharmacy.  
 
 “If I have a patient that’s on more than ten medicines I think 
that they should meet with the pharmacist and just go over 
it.”  G1 FMR M1 
“If they’re [pharmacists] not here, I have called the inpatient 
pharmacy before.” G2 FMR F2 
 
Hospital 
FMRs and FMF expressed that inpatient pharmacists have a 
significant role in medication safety and answering medication-
related questions. When in the hospital, FMRs reported that the 
pharmacist contacts the physician regarding medication safety 
issues, and the FMRs contact the pharmacist for medication-
related questions.  
 
“Inpatient [I] ask them to assist doing [a] drug interaction 
search or help with toxic zones or specifically dosing.”  
FMF M4 
“The pharmacists specifically are a nice safety net.”  
G1 FMR F2  
 
Community 
FMRs knew the least about community pharmacy practice. For 
most, their only communication with community pharmacists 
typically addressed insurance not covering a medication. FMF 
thought that more collaborative relationships with community 
pharmacists existed in rural locations because the physicians and 
pharmacists in the small community know each other personally. 
FMRs reported that most of the communication with community 
pharmacists came from the pharmacist to the FMR and was 
intended to clarify prescription orders.   
 
“What the community retail pharmacists are really useful for 
is [insurance] coverage issues.” G2 FMR M1 
“The community pharmacists are really on the other end of 
the phone and that’s really unfortunate. You don’t have any 
relationship or talk to them.” FMF M2 
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Theme 2: Physicians’ perceived benefits to collaboration 
The FMF and FMRs described multiple benefits of collaboration. 
These benefits included time efficiency, patient care safety, and 
provision of education to the FMRs.   
 
Time Efficiency 
FMRs expressed appreciation for time efficiency of their patient 
clinic visits after the pharmacist had seen the patient immediately 
prior.  
  
“If they see the patient before me, that’s really helpful 
because then I can say, ‘here’s five things that I should 
touch [on] today.” G2 FMR M2 
 
Patient Care Safety 
FMRs and FMF reported patient care was safer when pharmacists 
were involved, particularly in the hospital setting. 
 
“[The pharmacists have] more of a presence and it’s made 
the hospital a safer place because there are lots of 
medication errors and pharmacists tend to double check.” 
FMF M4 
 
FMR Education Provided by Pharmacists 
Didactic education provided by pharmacists was considered high 
quality, relevant, and well-delivered. Educational efforts by FMF 
and clinical pharmacists/residents were targeted to the FMR 
learners. FMR and FMF reported pharmacists were a helpful 
resource who knew about both preventive health issues (e.g., 
immunizations) and specific medication-related issues (e.g., 
dosing, entering medication orders in the electronic health 
record). 
 
“Their depth and breadth of knowledge, their willingness to 
dig deep into a topic, their willingness to teach. In our 
residency program, we have a chronic disease management 
curriculum, and the pharmacists have been integral in that 
process.” FMF F1 
“The pharm lectures are probably the highest yield lectures 
that we have.” G2 FMR M2 
 
However, there was not a reciprocal benefit to the pharmacists. 
 
“I didn’t really feel like we get a whole lot of education from 
them.” P F4 
 
Pharmacists providing education to the FMRs about the roles and 
responsibilities of the pharmacist on the team was seen as 
important by the FMRs and FMF. Most FMRs and FMF favored 
the idea that the FMRs need to understand what and how 
pharmacists do their work because if certain clinical pharmacy 
services are not available at future practice sites, FMRs should 
have the capability to quickly learn these skills, consult colleagues 
when necessary, and even advocate for practice change to 
include clinical pharmacy services.  
“Sometimes the residents are over reliant on the pharmacists 
to, for example, come up with an antibiotic dosing regimen.” 
FMF F4 
 
Theme 3: Keys to successful pharmacist-physician collaboration 
Successful collaborations between pharmacists and physicians 
were described in five domains: a) develop the relationship, b) 
optimize communication, c) create beneficial clinical workflow, d) 
clarify roles and responsibilities, and e) increase opportunities for 
meaningful interactions.  
 
Develop the Relationship 
The key components to developing an effective collaborative 
relationship that emerged from all groups included trust, respect, 
previous experiences, and access/availability 
. 
“I think mutual respect, too. If there’s ever any pointing 
fingers between one or the other about something wrong 
that’s starting off [on the wrong foot].” G3 FMR F4 
 
Optimize Communication 
FMRs would like access to a pharmacist they trust 24 hours a day 
and seven days a week, especially where they can communicate 
face-to-face in real time. They were not always certain how to 
access clinical pharmacy services (ambulatory or inpatient), when 
a pharmacist was not on site in the clinic. There was variability in 
the means and frequency with which FMRs access clinical 
pharmacy services (phone, electronic health record, email), 
although face-to-face seemed to be the preferred mode. If a 
pharmacist was not available to speak face-to-face, FMRs would 
contact pharmacists with whom they were familiar. The FMF also 
spoke to the value of having everybody in the same room at the 
same time and how that facilitated the ability to effectively 
communicate. They expressed a desire for this to be true in all 
settings where they interact with pharmacists. 
 
“The best thing we’ve done collaboratively is to actually put 
our interdisciplinary team in the same space.” FMF F3 
“I think definitely working side by side in the hospital or clinic 
makes a big difference.” G2 FMR M2 
 
Create Beneficial Clinical Workflow 
FMRs, FMF, and pharmacists thought the best model of practice 
was for the pharmacist to see the patient in the clinic before the 
FMR. The pharmacists captured a comprehensive medication list 
and provided recommendations to the FMR immediately before 
the FMR saw the patient. FMRs appreciated that pharmacists 
maintained the FMR-patient relationship by providing only 
education to the patients and making their recommendations 
about medication changes directly to the FMR rather than to the 
patient.  This communication protocol helped to prevent 
unreasonable patient expectations. 
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“The thing that’s nice about it is that they’ll discuss it with the 
patient, but the patient does not have the expectation that 
when I walk in the room that’s the changes I’m going to 
make” G2 FMR F2 
 
Clarify Roles/Responsibilities 
FMRs and FMF recognized that roles of pharmacy residents and 
pharmacists overlap. In the hospital and clinic, they viewed 
pharmacy residents as transient pharmacists, but used their 
services in the same manner as their clinical pharmacist 
preceptors.  
 
“They’re used interchangeably because the pharmacy 
residents are fabulous.” FMF F1 
 
Additionally, they recognized that some pharmacist and FMR 
patient care roles overlap (e.g., preventative care, medication 
review, and patient education). 
 
“[I am] impressed at how much clinical medicine and how 
many clinical guidelines the pharmacists know - even better 
than a lot of physicians.” G2 FMR M3  
 
No focus group participants clearly articulated a model for “team 
accountability” for patient care, but they recognized that if 
someone accepts the responsibility for a task, then they were 
accountable for the outcome. 
 
“If you asked that to be done, they took the baton. They’re 
dosing.  They’re responsible.” FMF F1 
 
Increase Opportunities for Meaningful Interactions 
FMRs felt getting to know their pharmacy colleagues would 
facilitate understanding roles and responsibilities and would 
promote collaboration. FMRs, FMF, and pharmacists described 
multiple ways to develop a collaborative relationship, including 
having inpatient and outpatient pharmacy residents, FMRs, and 
community pharmacists participate in resident orientation or 
inviting a community pharmacist to a noon conference and to see 
some patients together in clinic. FMF also suggested that 
pharmacists be faculty in the residency program and participate 
in faculty meetings. 
 
“A noon conference with a panel of small town pharmacists 
talking about how they work with physicians in those small 
communities.” FMF F2 
“I think it would be really beneficial to have a group meeting 
in the very beginning of the residency year.” P F2 
 
DISCUSSION 
A summary of findings and recommendations was presented to 
the residency program director and the interprofessional 
education advisory group members for their review and 
feedback. As a result, several changes were developed and 
implemented to facilitate collaboration, including enhanced 
interprofessional orientation activities, creation of collaborative 
practice agreements, and opportunities for FMRs to take an 
elective rotation with a community pharmacist (Appendix B).  
 
This study found that the pharmacist and physician groups, 
including residents, recognize the benefits of a collaborative care 
model, including time efficiency, patient care safety, and 
education of the medical residents.  It was surprising that the 
perceived benefits to collaboration in this study were consistent 
across all levels of medical residents. The expectation would be 
that greater exposure over time would have increased the 
benefits of collaboration.  Perhaps the level of collaboration is 
fixed, which limits the opportunities for enhanced benefits with 
increased exposure. 
 
There are, however, opportunities to improve the level of 
collaboration between pharmacists and physicians. Based on 
Brock and Doucette’s five stages of collaborative working 
relationships, the pharmacist-physician groups are working at a 
mid-stage.19 The two professions have moved beyond an 
awareness of each other (stage 0), and have built a foundation of 
trust (stage 1), within the clinic setting, and are now beginning to 
assess the pharmacist’s clinical abilities within that clinical setting 
(stage 2). Except in the case of questions specifically about 
medication management or for referral for disease-specific 
interventions, such as anticoagulation management, there is not 
yet interdependence on one another (stage 3). The pharmacist is 
still the primary initiator of clinical partnerships.19 To fully move 
to the final stage, Commitment to Collaborative Working 
Relationship (stage 4), the physicians would have to see that the 
benefits of collaboration outweigh any risks and that there is 
consistent input and physical pharmacist presence.19 This study 
identified five keys to a successful collaboration between 
pharmacists and physicians, which could assist in moving resident 
physicians and pharmacists to higher stages of collaboration. 
These include developing relationships, optimizing 
communication, creating beneficial clinical workflow, clarifying 
roles and responsibilities, and increasing opportunities for 
meaningful interactions. There are many strategies for advancing 
these keys to successful collaboration. The study participants 
mentioned such things as co-locating the two professions, 
inviting more people to noon conferences, and improving the 
ability to access each other’s services at all times of the day. 
Pharmacists can also explicitly educate physicians about what 
occurs in a medication management visit, the types of patients 
that could benefit, and provide clear instructions about how to 
refer patients for pharmacy services.9 Another intervention is to 
increase the frequency of face-to-face interactions, which will 
help to develop a relationship that increases trust between the 
professions.28,29 It is also important to emphasize how the work 
of the two professions can be complementary and reinforce the 
benefits of each other’s expertise such that there is a win-win 
relationship.19 
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A limitation of this study is that it occurred in only one site; 
research in additional sites may yield further insights. 
Additionally, there were not enough family medicine faculty from 
the different professions to analyze their data separately. The 
knowledge and perceptions of the pharmacy residents and 
faculty may vary among the faculty professions, and further 
research is warranted. Future research is needed to measure the 
impact of increased pharmacist-FMR collaboration on patient 
care outcomes, and also to explore collaboration with integrated 
behavioral health faculty and learners. 
 
CONCLUSION 
Enhanced collaboration will evolve and strengthen in a clinical 
environment where each team member knows the roles of each 
profession and uses those roles to optimize the way the 
professionals communicate, interact, and provide patient care. 
This study in a practice with relatively new clinical pharmacy 
services shows that by co-locating physicians and pharmacists in 
the same setting, and providing a basic structure for 
collaboration, a collaborative working relationship can be 
facilitated. Practices looking to have more effective collaborative 
working relationships should strive to increase the frequency of 
interactions of the professionals, help the physicians understand 
the abilities of pharmacists, and help the pharmacists articulate 
to the physicians the value of what they provide to patients. The 
five keys to successful collaboration identified in this study are 
building blocks to advance a robust collaborative working 
relationship that positively benefits patient care and achieves the 
Quadruple Aim. 
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Table 1. Main Themes and Subthemes 
 
1. Roles of pharmacists in different settings were recognized by physicians   
     a. Clinic – medication therapy management and adherence 
     b. Hospital – medication safety and medication-specific questions 
     c. Community – medication coverage and dose clarification 
2. Physicians’ perceived benefits to collaboration 
     a. Time efficiency 
     b. Patient care safety 
     c. FMR education provided by pharmacists 
3. Keys to successful pharmacist-physician collaboration 
     a. Develop the relationship 
     b. Optimize communication 
     c. Create beneficial clinical workflow 
     d. Clarify roles/responsibilities 
     e. Increase opportunities for meaningful interactions 
 
 
 
Appendix A. Family Medicine Resident Focus Group Interviewer Guide 
 
15 min (1) Who makes up the health care team?  
PROBES:  
Who are the team members?  
What are their roles and responsibilities? 
10 min (2) There are pharmacists that work here in the clinic. Describe what the pharmacists in 
the clinic here do. 
PROBES:  
Describe how this compares with what the pharmacists in the hospital do.  
How about in “retail” or community pharmacy?  
What is the pharmacist’s scope of practice? 
What is the pharmacist’s role/responsibility in team-based care? 
10 min (3) Describe how you interact with the pharmacists in the clinic. 
PROBE: 
Describe how this compares with how you interact with pharmacists in the hospital or 
retail/community. 
10 min (4) When and how is collaborative team-based care beneficial for patients? 
10 min (5) What do you expect from collaboration? 
 
10 min (6) Describe how to develop collaborative relationships amongst patient care providers 
from different professions. 
10 min (7) Do you have ideas about additional collaborative opportunities with pharmacists to 
enhance patient care? 
PROBE: 
Maybe something you’ve seen in other practice settings? 
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Appendix B. Practice and Education Changes in Response to Focus Group Results 
• Clinical pharmacists are now family medicine residency (FMR) program faculty 
• Enhanced orientation with first-year FMRs 
o Team member roles/responsibilities modified team-based learning quiz 
o Team care conference labeling/stereotype exercise  
o Shadowing clinical pharmacists 
o Group polypharmacy patient case review done by first-year family medicine residents and pharmacy 
residents together; case is facilitated by pharmacy faculty 
• Implementation/utilization of Collaborative Practice Agreements (CPAs) at the residency program clinic: 
o Developing a Type 2 Diabetes non-insulin CPA to be utilized with 3rd year medical residents 
o Opioid taper CPA* 
o Tobacco cessation CPA 
• Pharmacist Documentation  
o Continue to write detailed but appropriate notes that are good for learning/teaching 
• Pharmacist Workflow 
o Continue/strive for back-to-back patient visits 
o Conduct co-visits for observation/teaching/evaluating* 
• Exposure to community pharmacy practice 
o Opportunity for one FMR per month to shadow a community pharmacist 
o At this time, this is not required but considering making this a requirement in the future 
• Opportunities for pharmacy residents to attend medical residency lectures/learning 
o Invitations sent to pharmacy residents via email 
o Set up a generic pharmacy resident access to New Innovations to access the lecture calendar* 
• Drug Information Questions* 
o Answers to medication questions posed to the pharmacy pool will be de-identified and shared with all 
residents for learning purposes 
• Huddles* 
o Occur at 8:15 AM and 1:15 PM on the second floor first and then first floor 
o Pharmacists will attend 
 
*Not yet fully implemented as of September 2017. 
 
 
 
